Wildcat Capital Management, LLC

13D and 13G Filings

Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
Silexion Therapeutics Corp 13D/A
SLXN · G1281K122
1.3% 6/26/2025
Event 6/26/2025
Schedule 13G · 1 security · passive
Vicapsys Life Sciences, Inc. 13G
VICP · 92560A106
18.8% 3/21/2025
Event 4/20/2020

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.